FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:1344-1346 September 23, 2004 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Anavekar, N. S. Related Article by Go, A. S. PubMed Citation

The prevalence of end-stage renal disease continues to rise in the United States. Even more disturbingly, the current number of patients with early chronic kidney disease — the pool from which future end-stage renal disease patients will emerge — exceeds the present number with end-stage renal disease by a factor of 30 to 60.^1,2 However, early chronic kidney disease will not progress to end-stage renal disease in all patients. Indeed, many will probably die of other conditions first. Over the past few years, investigators have shown that many people in this vast pool of patients with chronic kidney disease have . . . [Full Text of this Article]

Source Information

From the National Kidney Disease Education Program, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Md.

This article has been cited by other articles:

• Kiski, D., Stepper, W., Brand, E., Breithardt, G., Reinecke, H. (2009). Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial. Nephrol Dial Transplant 0: gfp582v1-gfp582 [Abstract] [Full Text]  
• Covic, A., Kothawala, P., Bernal, M., Robbins, S., Chalian, A., Goldsmith, D. (2009). Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease. Nephrol Dial Transplant 24: 1506-1523 [Abstract] [Full Text]  
• McCarthy, J. T., Rule, A. D., Achenbach, S. J., Bergstralh, E. J., Khosla, S., Melton, L. J. III (2008). Use of Renal Function Measurements for Assessing Fracture Risk in Postmenopausal Women. Mayo Clin Proc. 83: 1231-1239 [Abstract] [Full Text]  
• Cirillo, M., Lanti, M. P., Menotti, A., Laurenzi, M., Mancini, M., Zanchetti, A., De Santo, N. G. (2008). Definition of Kidney Dysfunction as a Cardiovascular Risk Factor: Use of Urinary Albumin Excretion and Estimated Glomerular Filtration Rate. Arch Intern Med 168: 617-624 [Abstract] [Full Text]  
• Karagiannis, S. E., Feringa, H. H.H., Elhendy, A., van Domburg, R., Chonchol, M., Vidakovic, R., Bax, J. J., Karatasakis, G., Athanasopoulos, G., Cokkinos, D. V., Poldermans, D. (2008). Prognostic significance of renal function in patients undergoing dobutamine stress echocardiography. Nephrol Dial Transplant 23: 601-607 [Abstract] [Full Text]  
• Authors/Task Force Members, , Bassand, J.-P., Hamm, C. W., Ardissino, D., Boersma, E., Budaj, A., Fernandez-Aviles, F., Fox, K. A.A., Hasdai, D., Ohman, E. M., Wallentin, L., Wijns, W., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Kristensen, S. D., Widimsky, P., McGregor, K., Sechtem, U., Tendera, M., Hellemans, I., Gomez, J. L. Z., Silber, S., Funck-Brentano, C., Document Reviewers, , Kristensen, S. D., Andreotti, F., Benzer, W., Bertrand, M., Betriu, A., De Caterina, R., DeSutter, J., Falk, V., Ortiz, A. F., Gitt, A., Hasin, Y., Huber, K., Kornowski, R., Lopez-Sendon, J., Morais, J., Nordrehaug, J. E., Silber, S., Steg, P. G., Thygesen, K., Tubaro, M., Turpie, A. G.G., Verheugt, F., Windecker, S. (2007). Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 28: 1598-1660 [Full Text]  
• Rule, A. D., Rodeheffer, R. J., Larson, T. S., Burnett, J. C. Jr, Cosio, F. G., Turner, S. T., Jacobsen, S. J. (2006). Limitations of Estimating Glomerular Filtration Rate From Serum Creatinine in the General Population. Mayo Clin Proc. 81: 1427-1434 [Abstract] [Full Text]  
• Smith, G. L., Shlipak, M. G., Havranek, E. P., Foody, J. M., Masoudi, F. A., Rathore, S. S., Krumholz, H. M. (2006). Serum urea nitrogen, creatinine, and estimators of renal function: mortality in older patients with cardiovascular disease.. Arch Intern Med 166: 1134-1142 [Abstract] [Full Text]  
• Kimmel, P. L. (2006). Update in nephrology and hypertension.. ANN INTERN MED 144: 281-285 [Full Text]  
• Schrier, R. W. (2006). Role of Diminished Renal Function in Cardiovascular Mortality: Marker or Pathogenetic Factor?. J Am Coll Cardiol 47: 1-8 [Abstract] [Full Text]  
• Barr, D. A. (2005). The Practitioner's Dilemma: Can We Use a Patient's Race To Predict Genetics, Ancestry, and the Expected Outcomes of Treatment?. ANN INTERN MED 143: 809-815 [Abstract] [Full Text]  
• Rule, A. D., Textor, S. C. (2005). Cardiovascular Risk Linked to Chronic Kidney Disease--But Who Actually Has Chronic Kidney Disease?. Mayo Clin Proc. 80: 1267-1269  
• McKie, P. M., Burnett, J. C. Jr (2005). B-Type Natriuretic Peptide as a Biomarker Beyond Heart Failure: Speculations and Opportunities. Mayo Clin Proc. 80: 1029-1036 [Abstract]  
• Harlan, D. M., McBride, M. A. (2005). Survival After Pancreas Transplantation--Reply. JAMA 293: 675-676 [Full Text]